US 12084502
CD33-binding polypeptides and uses thereof
granted A61KA61K45/06A61K47/55
Quick answer
US patent 12084502 (CD33-binding polypeptides and uses thereof) held by Inhibrx Biosciences, Inc. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx Biosciences, Inc.
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K45/06, A61K47/55, A61P, A61P35/00